Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anacetrapib in Japanese Patients with Dyslipidemia
NCT01760460Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of anacetrapib in dyslipidemia, sponsored by Merck & Co.. Started Mar 2013; status: completed.
02
Drugs
anacetrapib
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01760460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01760460.